Physician profile
Dennis Orr
NPI 1376715391
$10,356.16
in general payments reported to CMS, 2019-2025
25 companies · $365 in 2025
The $365 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,761 · 2020: $569 · 2021: $799 · 2022: $922 · 2023: $937 · 2024: $3,003 · 2025: $365.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,536 · Education: $1,500 · Travel and Lodging: $1,269.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,535.90 |
| Education | $1,500.00 |
| Travel and Lodging | $1,269.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,284.60 | 2019-2025 | Da Vinci Surgical System |
| Medical Device Business Services, INC. | $1,810.88 | 2019 | |
| Ethicon US, LLC | $983.84 | 2019-2023 | Linx Reflux Management System, Echelon Flex |
| Davol INC. | $821.83 | 2019-2023 | Phasix Mesh |
| Allergan, INC. | $681.87 | 2019-2022 | |
| Tela Bio, INC. | $533.87 | 2019-2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Medtronic, INC. | $250.82 | 2021-2023 | Signia, Progrip |
| Boston Scientific Corporation | $178.51 | 2019-2023 | Resolution 360 Clip |
| Conmed Corporation | $151.64 | 2024 | Conmed Generators, Conmed Hemostasis, Conmed Biliary |
| Sanara Medtech INC. | $127.57 | 2023 | Celleraterx |
| Covidien Lp | $112.28 | 2019-2020 | |
| Amgen INC. | $80.16 | 2024-2025 | Repatha, Otezla, Otezla |
| Abbvie INC. | $63.90 | 2023 | |
| Evoke Pharma, INC. | $53.97 | 2025 | |
| Endogastric Solutions, INC | $31.88 | 2019 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Reprise Biomedical, INC. | $24.95 | 2024 | Miro3d |
| Redhill Biopharma INC. | $24.10 | 2024 | Talicia |
| Glaxosmithkline, LLC. | $22.58 | 2024 | Arexvy, Trelegy Ellipta |
| Cook Medical LLC | $22.29 | 2019 | |
| Exact Sciences Corporation | $18.61 | 2025 | The Cologuard Plus Collection Kit |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $18.30 | 2025 | Caplyta |
| Astrazeneca Pharmaceuticals Lp | $18.13 | 2025 | Farxiga |
| Lilly USA, LLC | $15.40 | 2024 | Zepbound, Jardiance |
| Phathom Pharmaceuticals, INC. | $12.15 | 2025 | Voquezna |
| Innocoll Pharmaceuticals Limited | $12.03 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dennis Orr listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.